Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Translocation 1;7 in preleukemic states.

N Smadja, M Krulik, A de Gramont

    Cancer Genetics and Cytogenetics
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ARCAD-Asia initiative: leveraging yesterday's data for tomorrow.

    ESMO gastrointestinal oncology·2026
    Same author

    Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis.

    ESMO open·2025
    Same author

    Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.

    British journal of cancer·2024
    Same author

    Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
    Same author

    MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF<sup>wt</sup> metastatic colorectal cancer.

    ESMO open·2022
    Same author

    Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same journal

    Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

    Cancer genetics and cytogenetics·2010
    Same journal

    A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

    Cancer genetics and cytogenetics·2010
    Same journal

    A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

    Cancer genetics and cytogenetics·2010
    Same journal

    Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

    Cancer genetics and cytogenetics·2010
    Same journal

    Chromosomal imbalances in urinary bladder paraganglioma.

    Cancer genetics and cytogenetics·2010
    Same journal

    A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

    Cancer genetics and cytogenetics·2010
    See all related articles

    This study details two new cases of a specific chromosomal abnormality, the t(1;7) translocation, observed in patients with hematologic disorders. This finding adds to the limited understanding of this rare genetic alteration in blood diseases.

    Area of Science:

    • Cytogenetics
    • Hematology
    • Human Genetics

    Background:

    • The t(1;7) translocation, specifically t(1;7)(p11;p11), is a rare chromosomal abnormality.
    • This translocation results in trisomy for the 1q region and monosomy for the 7q region in abnormal cells.
    • Previously reported in eight patients with hematologic disorders, with four additional cases found in the literature.

    Observation:

    • This report presents two new patients exhibiting the t(1;7) translocation.
    • The karyotype analysis confirmed trisomy 1q and monosomy 7q in the abnormal cells of these patients.

    Findings:

    • The two new cases contribute to the small but growing body of evidence on t(1;7)(p11;p11).
    • Consistent karyotypic findings (trisomy 1q, monosomy 7q) are observed across reported cases.

    Related Experiment Videos

    Implications:

    • Further research is needed to elucidate the specific role of t(1;7)(p11;p11) in the pathogenesis of hematologic disorders.
    • Understanding this translocation may aid in diagnosis and prognosis for affected individuals.
    • Adds to the cytogenetic knowledge base for hematologic malignancies.